TKNO Stock Summary and Trading Ideas (Alpha Teknova | NASDAQ:TKNO)

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Alpha Teknova trades on the NASDAQ stock market under the symbol TKNO.

As of December 29, 2025, TKNO stock price declined to $3.87 with 617,906 million shares trading.

TKNO has a beta of 1.71, meaning it tends to be more sensitive to market movements. TKNO has a correlation of 0.19 to the broad based SPY ETF.

TKNO has a market cap of $207.10 million. This is considered a Small Cap stock.

Last quarter Alpha Teknova reported $10 million in Revenue and -$.08 earnings per share. This beat revenue expectation by $222,170 and exceeded earnings estimates by $.01.

In the last 3 years, TKNO traded as high as $10.37 and as low as $1.16.

The top ETF exchange traded funds that TKNO belongs to (by Net Assets): VTI, IWM, VXF, IWO, IBB.

TKNO has underperformed the market in the last year with a price return of -56.9% while the SPY ETF gained +15.6%. TKNO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -36.2% and -17.8%, respectively, while the SPY returned +4.2% and +1.2%, respectively.

TKNO support price is $3.83 and resistance is $4.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TKNO shares will trade within this expected range on the day.